RELATED CONTENT
NEWS
- Novartis' new Gilenya data fails to address NICE concerns as final decision looms
- NICE blow for Novartis' Gilenya could be good news for Biogen
- Novartis won't take 'hint' as German HTA says Gilenya offers little additional benefit
- Scots choose chewy Lipitor but refuse Zytiga, Sycrest and Gilenya
ANALYSIS
Other Informa Analysis
FEATURES
Other Informa Features
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

